SecBot SecBot
SECBOTREPLAY Home › Report › TRDA

TRDA · 5AM Ventures V, L.P., an early venture investor and affiliated…

Entrada Therapeutics, Inc. · 144 filed Jul 30, 2026 at 17:39 ET

At the news

BEARISHIMPACT 5/10

144 filed Jul 30, 2026 at 17:39 ET

5AM Ventures V, L.P., an early venture investor and affiliated stockholder of Entrada Therapeutics, filed a Form 144 notice of intent to sell 331,156 shares of common stock, valued at approximately $2.17 million. The proposed sale represents about 0.85% of shares outstanding and signals potential portfolio distribution by a long-term holder.

  • 5AM Ventures V, L.P. proposes to sell 331,156 shares of Entrada Therapeutics common stock.
  • Estimated market value of the proposed sale is $2,169,072.
  • Shares were acquired on October 12, 2016 via venture financing investment.
  • The sale is to be executed through Goldman Sachs & Co. LLC.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access